Cytokinetics Inc (CYTK): Total Assets
$1.42B
As of 2025-12-31
$1.92B
As of 2026-06-30
+12.0%
3-year compound annual growth
+21.7%
5-year compound annual growth
+28.6%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.42B | +1.6% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $1.40B | +70.0% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $824.32M | -18.8% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $1.01B | +20.6% | 2024-02-28, Balance as of period end |
| 2021-12-31 | $841.32M | +57.6% | 2023-03-01, Balance as of period end |
| 2020-12-31 | $533.80M | +84.2% | 2022-02-25, Balance as of period end |
| 2019-12-31 | $289.81M | +37.2% | 2021-02-26, Balance as of period end |
| 2018-12-31 | $211.18M | -28.4% | 2020-03-04, Balance as of period end |
| 2017-12-31 | $294.81M | +73.3% | 2019-03-07, Balance as of period end |
| 2016-12-31 | $170.14M | +47.6% | 2018-03-05, Balance as of period end |
| 2015-12-31 | $115.24M | -13.3% | 2017-03-06, Balance as of period end |
| 2014-12-31 | $132.97M | +59.8% | 2016-03-03, Balance as of period end |
| 2013-12-31 | $83.19M | +7.3% | 2015-03-06, Balance as of period end |
| 2012-12-31 | $77.55M | +47.0% | 2014-03-07, Balance as of period end |
| 2011-12-31 | $52.77M | -32.3% | 2013-03-15, Balance as of period end |
| 2010-12-31 | $77.99M | n/a | 2012-03-13, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Cytokinetics Inc (CYTK) | 2025-12-31 | $1.42B | +1.6% |
| Standard Biotools Inc. (LAB) | 2025-12-31 | $567.75M | -7.3% |
| ARS Pharmaceuticals, Inc. (SPRY) | 2025-12-31 | $327.65M | -6.7% |
| Nurix Therapeutics, Inc. (NRIX) | 2025-11-30 | $688.13M | +2.8% |
| Arcturus Therapeutics Holdings Inc. (ARCT) | 2025-12-31 | $271.15M | -21.2% |
| Siga Technologies Inc (SIGA) | 2025-12-31 | $219.47M | -10.2% |
| ADC Therapeutics SA (ADCT) | 2025-12-31 | $323.15M | +0.4% |
| Eton Pharmaceuticals, Inc. (ETON) | 2025-12-31 | $92.11M | +21.0% |
| CytomX Therapeutics, Inc. (CTMX) | 2025-12-31 | $151.57M | +25.7% |
Compare CYTK, LAB, SPRY, NRIX side by side · Screen every company in Pharmaceutical Preparations ↗